InsidersTradesSigma
지투지바이오 Stock: price and insider trades · South Korea · DART (FSS)
Track the 지투지바이오 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 지투지바이오 has published 6 reports. Market capitalisation: €500.5bn. The latest transaction was filed on 5 June 2026 (Purchase). Among the most active insiders: 이희용. Every trade is accessible without an account.
6
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
1 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 5 June 2026
Declarations6 total
6 of 6 declarations
About 지투지바이오
지투지바이오 is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative biopharmaceutical solutions.